SNTI
Price
$4.67
Change
+$0.48 (+11.46%)
Updated
Jan 17 closing price
Capitalization
21.43M
VERV
Price
$6.14
Change
+$0.04 (+0.66%)
Updated
Jan 17 closing price
Capitalization
519.84M
38 days until earnings call
Ad is loading...

SNTI vs VERV

Header iconSNTI vs VERV Comparison
Open Charts SNTI vs VERVBanner chart's image
Senti Biosciences
Price$4.67
Change+$0.48 (+11.46%)
Volume$137.4K
Capitalization21.43M
Verve Therapeutics
Price$6.14
Change+$0.04 (+0.66%)
Volume$1.65M
Capitalization519.84M
SNTI vs VERV Comparison Chart
Loading...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNTI vs. VERV commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNTI is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (SNTI: $4.67 vs. VERV: $6.14)
Brand notoriety: SNTI and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNTI: 4% vs. VERV: 104%
Market capitalization -- SNTI: $21.43M vs. VERV: $519.84M
SNTI [@Biotechnology] is valued at $21.43M. VERV’s [@Biotechnology] market capitalization is $519.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNTI’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • SNTI’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, both SNTI and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNTI’s TA Score shows that 1 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • SNTI’s TA Score: 1 bullish, 3 bearish.
  • VERV’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VERV is a better buy in the short-term than SNTI.

Price Growth

SNTI (@Biotechnology) experienced а +18.83% price change this week, while VERV (@Biotechnology) price change was +11.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

SNTI is expected to report earnings on Aug 12, 2024.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($520M) has a higher market cap than SNTI($21.4M). SNTI YTD gains are higher at: 33.048 vs. VERV (8.865). SNTI has higher annual earnings (EBITDA): -57.12M vs. VERV (-219.97M). VERV has more cash in the bank: 540M vs. SNTI (10.5M). SNTI has less debt than VERV: SNTI (34.7M) vs VERV (71.3M). VERV has higher revenues than SNTI: VERV (24.4M) vs SNTI (0).
SNTIVERVSNTI / VERV
Capitalization21.4M520M4%
EBITDA-57.12M-219.97M26%
Gain YTD33.0488.865373%
P/E RatioN/AN/A-
Revenue024.4M-
Total Cash10.5M540M2%
Total Debt34.7M71.3M49%
TECHNICAL ANALYSIS
Technical Analysis
SNTIVERV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
65%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
48%
Bullish Trend 12 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
59%
Bullish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
70%
Bearish Trend 12 days ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
Bearish Trend 12 days ago
76%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PFGKX35.380.23
+0.65%
Pioneer Fundamental Growth K
EQNVX21.830.12
+0.55%
MFS Equity Income R6
IVAEX22.230.11
+0.50%
Macquarie Asset Strategy Fund Cl I
MMQYX7.390.03
+0.41%
MassMutual Small Cap Val Eq Svc
BHCFX19.40-0.14
-0.72%
Baron Health Care Retail

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
+11.46%
PPBT - SNTI
53%
Loosely correlated
-4.84%
TCRT - SNTI
47%
Loosely correlated
+4.05%
INBX - SNTI
41%
Loosely correlated
-0.37%
PTCT - SNTI
33%
Poorly correlated
+1.76%
VERV - SNTI
32%
Poorly correlated
+0.66%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+0.66%
BEAM - VERV
54%
Loosely correlated
+0.17%
CRSP - VERV
53%
Loosely correlated
+0.57%
PRME - VERV
49%
Loosely correlated
+0.70%
EDIT - VERV
49%
Loosely correlated
-1.61%
NTLA - VERV
48%
Loosely correlated
+0.85%
More